Francisco Miguel Cruz Uréndez


Graduated in Biochemistry from the University of Granada (2009), he joined at CNIC through a CICERONE scholarship and a Master's scholarship under the tutelage of Dr. Antonio Bernad, where he studied the role of microRNAs in the differentiation processes of cardiac progenitor stem cells Sca-1 +. In 2012 he obtained a FPU scholarship to pursue his doctoral studies in the laboratory of Dr. Juan Bernal, at the CNIC. During this period, he pioneered the application of a new approach to generate transgenic animals by transduction in healthy animals with adeno-associated virus (AAV) with a single objective: from bench to disease model. Thus, he focused his studies on arrhythmogenic right ventricular cardiomyopathy (ARVC) demonstrating that exercise induces pathology in PKP2 mutants. During his doctorate, he moved to St. Marianna University School of Medicine in Kawasaki, Japan (2015) to study the cardiotoxic role of anthracyclines during cancer treatment. He finally obtained his PhD in 2017 with the highest rating of Cum laude. That same year, he completed higher studies in Business Creation and Management (Executive MBA) and founded his own company in Granada to offer alternative solutions to the use of plastic in the food sector. He is currently the intellectual owner of the brand “Si Quiero. Vitaminas y eso que te llevas”, actually active. In 2019, he joined the laboratory of Dr. José Jalife to generate mutant models of Kir2.1 and study at the molecular and electrophysiological level the mechanisms underlying the arrhythmogenic events of Andersen-Tawil Syndrome type 1 (ATS1).